Skip to content
Search

Latest Stories

CCA estimates community pharmacy to experience equivalent of three fallow years by 2024

The Company Chemists Association (CCA)’s workforce finding showed that by 2024 eight years’ worth of growth of the pharmacist workforce will have been funnelled away from community pharmacies.

“In 2019, when NHS leaders realised they were unable to find enough GPs to meet the public’s needs, they hastily decided to recruit pharmacists and other healthcare professionals to fill the gaps. This was implemented without any corresponding efforts to increase the supply of pharmacists, creating huge shortages,” said CCA.


“The bulk of the NHS’s recruitment drive was paid for using additional money ringfenced by the NHS – the £2.4bn Additional Roles Reimbursement Scheme (ARRS). We estimate over the life course of ARRS funding (2019-2024), the equivalent of eight years of growth in the number of pharmacists in England will have been funnelled directly into primary care at the expense of other sectors.

At the current rate, CCA estimate that community pharmacy will have experienced the equivalent of three fallow years by 2024.

To ensure the pharmacy network is protected and able to take pressure off other parts of the NHS, there are several urgent measures which must be implemented.

Countering the impact of primary care recruitment: Community pharmacists should be commissioned to provide ‘packages of care’ on behalf of GPs, rather than taking pharmacists away from accessible high street settings.

Funding: an immediate uplift of funding for pharmacies is needed to meet spiralling costs and enable investment in staff to ease pressure and support retention.

Pharmacy First: The Government should immediately implement a fully-funded Pharmacy First service in England. This would enable patients with minor conditions to be seen, diagnosed, and treated at their local pharmacy, freeing up GP capacity.

Malcolm Harrison, the Chief Executive of the CCA said: “The Government must act without delay on the ever-deepening community pharmacy workforce crisis.

Although GP recruitment of pharmacists is not the only factor contributing to the workforce crisis, it is undoubtedly fanning the flames. This downward spiral is creating untenable pressure on pharmacists and their teams.

Robbing Peter to pay Paul is short-sighted and such ‘whack-a-mole’ policies are doing more harm than good to patients.

The Government must devise an evidence-led workforce plan for all professions across primary care, ensuring patients can access the care that they need when and where they need it.”

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less